Events
Dissertation: Petra Kotanen
HiLIFE webinar / Biomedicum Helsinki seminar: Stephen Polyak
Dr. Polyak is a Research Professor in the Virology Division of the Department of Laboratory Medicine and Pathology at the University of Washington in Seattle. He also holds adjunct faculty appointments in the Departments of Global Health and Microbiology. Dr. Polyak received his Ph.D. in Molecular Virology and Immunology at McMaster University, Hamilton, Ontario, Canada, in 1993. After post-doctoral training at the University of Washington, Dr. Polyak was appointed to the faculty in February of 2000.
Dr. Polyak’s laboratory studies virus-host interactions, including work on flaviviruses (hepatitis C virus and Zika virus), filoviruses (Ebola and Marburg, arenaviruses (Lassa, Junin, and Pichinde), and more recently, coronaviruses (SARS-CoV-2). Work involves characterizing innate antiviral and inflammatory responses to virus infection, natural products that combat virus infection and virus-induced inflammation, and development of synergistic drug combinations for viral pandemic preparedness and response.
Dr. Polyak’s work has been supported by the National Institutes of Health (NIH) including NIAID, NIDDK, NCCIH, and NIAAA. He is an editorial board member and/or reviewer for several virology and cell biology journals. He regularly reviews grant applications for the NIH and internationally for multiple countries including Belgium, Canada, England, Ireland, Malaysia, Singapore, France, Netherlands, and the Czech Republic.
Twitter: @PolyakSteve
Welcome to this exciting seminar!
Tero Aittokallio and Franziska Bentz
Selected publications:
Herring S, Oda JM, Wagoner J, Kirchmeier D, O'Connor A, Nelson EA,
Huang Q, Liang Y, Evans DeWald L, Johansen LM, Glass PJ, Olinger GG,
Ianevski A, Aittokallio T, Paine MF, Fink SL, White JM, Polyak SJ.
Inhibition of Arenaviruses by Combinations of Orally Available
Approved Drugs. Antimicrob Agents Chemother. 2021 Jan 19:AAC.01146-20.
doi: 10.1128/AAC.01146-20. PMID: 33468464.
JM White, JT Schiffer, RA Bender Ignacio, S Xu, D Kainov, A Ianevski, T Aittokallio, M Frieman, GG Olinger, SJ Polyak. Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses. mBio. 2021 Dec 21;12(6):e0334721. doi: 10.1128/mbio.03347-21. Epub 2021 Dec 21. PMID: 34933447.
J Wagoner, S Herring, T-Y Hsiang, A Ianevski, SB Biering, S Xu, M Hoffmann, S Pöhlmann, M Gale Jr., T Aittokallio, JT Schiffer, JM White, SJ Polyak. Combinations of host- and virus-targeting antiviral drugs confer synergistic suppression of SARS-CoV-2. Microbiology Spectrum 2022. Oct 3;e0333122. doi: 10.1128/spectrum.03331-22. PMID: 36190406.
Kliinisen kemian seminaari: Sverre Sandberg
Tallenteen jälkeen yhteistä keskustelua
Biostatistics drop-in workshop *registration required*
Are you a researcher needing support with any statistical aspect of your work? The Biostatistics Consulting Service here at Meilahti Campus holds drop-in workshop sessions every other week to answer smaller questions about your analysis - solving a particular problem, how to get started, etc. We provide service in Finnish, English and Swedish.
The next workshop is on Wednesday 26th April, at 13:00-15:00 in Biomedicum 2B, in the Olohuone on floor 6. Come whenever you can. Note that you may end up waiting a while for your turn, especially early on in the session. We are currently short-staffed and will therefore have a strict 10-minute limit per customer. For longer questions, please consider a one-on-one consultation instead.
Bring:
· your computer
· your data
· your questions
and we biostatisticians will be on hand to help and guide.
Unlike normal, registration is required this week by filling in this form. The workshops are open to any researcher at the university's Medical Faculty, HUS or FIMM.
The next sessions are planned for at least 10.5, and 24.5. For more in-depth questions, please book a one-on-one consultation session using this e-form where we will have time to go into more detail.
From the Biostatistics Team